The full verification pipeline applied to every Chempeptides batch — HPLC, mass spectrometry, water content, peptide content, and cold-chain.

How semaglutide (Ozempic) drives weight loss in research models — GLP-1 receptor activation, appetite signalling, and STEP trial endpoints.

Tirzepatide (Mounjaro) is the first dual GLP-1/GIP receptor agonist. SURMOUNT trial data, mechanism, and why two receptors beat one.